QUEST DIAGNOSTICS INC Earnings Per Share Disclosure
| 2025 | 2024 | 2023 | |||||||||||||||
| Amounts attributable to Quest Diagnostics’ common stockholders: | |||||||||||||||||
| Net income attributable to Quest Diagnostics | $ | 992 | $ | 871 | $ | 854 | |||||||||||
| Less: Earnings allocated to participating securities | 4 | 5 | 4 | ||||||||||||||
Earnings available to Quest Diagnostics’ common stockholders – basic and diluted | $ | 988 | $ | 866 | $ | 850 | |||||||||||
| Weighted average common shares outstanding – basic | 111 | 111 | 112 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
| Stock options and performance share units | 2 | 2 | 1 | ||||||||||||||
| Weighted average common shares outstanding – diluted | 113 | 113 | 113 | ||||||||||||||
| Earnings per share attributable to Quest Diagnostics’ common stockholders: | |||||||||||||||||
| Basic | $ | 8.87 | $ | 7.78 | $ | 7.59 | |||||||||||
| Diluted | $ | 8.75 | $ | 7.69 | $ | 7.49 | |||||||||||
Want the next QUEST DIAGNOSTICS INC earnings per share disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment QUEST DIAGNOSTICS INC's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 20, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 21, 2023 | |
| 2021 | Feb 28, 2022 | |
| 2020 | Feb 22, 2021 | |
| 2019 | Feb 20, 2020 | |
| 2018 | Feb 21, 2019 | |
| 2017 | Feb 23, 2018 | |
| 2016 | Feb 22, 2017 | |
| 2015 | Feb 26, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.